
Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
India Ratings cut Jana Holdings and subsidiary bonds to “default” after debenture holders extended ₹4,200 crore repayments to Dec 31, 2026 amid failed refinancing and stake-sale plans.
Social media discussions point to weak earnings, heavy FPI selling, IT’s AI-driven reset, derivatives-led volatility, and tax-currency headwinds as key reasons for Nifty’s stagnation.
Wipro slipped to Rs 170.13 as Nifty IT hit a fresh 52-week low, with sentiment weighed down by US rate fears, Accenture guidance, and AI disruption concerns.
Airtel and Vodafone Idea track a spectrum-charge court ruling, while NLC India’s OFS, BPCL’s refinery updates and tax demand, and Airtel Money funding plans drive stock-specific moves.
Nifty reclaiming 24,000 triggered a sharp risk-on bounce as banks and IT led, helped by softer crude, RBI rate comments, and FII buying, with key risks still open.
Dhanlaxmi Bank said Q1 FY27 total business rose 21.12% year-on-year to ₹35,188 crore, led by higher deposits, faster advance growth, and a sharp rise in gold loans.
Sai Parenterals’ Australian arm Noumed signed a 7.5-year OTC supply pact worth about ₹1,300 crore from July 1, 2026, with annual new product additions planned.
The Bombay High Court granted interim relief allowing the Mumbai Gandhi family branch to keep using the Vadilal brand, reviving a long-running trademark and governance tussle.
AVG Logistics reported a sharp Q4 FY26 profit rise on stronger margins and outlined its Vision 2.0 plan to scale revenue to ₹1,250 crore by 2030.
CSM Technologies’ ₹145.78-crore IPO heads to allotment on June 30, 2026, with muted subscription and grey market cues pointing to a modest listing on July 2.
Lupin drew attention after USFDA and EMA updates, while V-Mart posted strong Q1 growth, NMDC reported higher June output, and Coal India disclosed e-auction volumes and pricing.
Aster DM Healthcare said NCLT Hyderabad sanctioned its QCIL amalgamation scheme, which becomes effective after ROC filing; shareholders backed it 96.68%, with completion targeted in Q1 FY27.
Hyderabad-based Sai Parenterals’ Australian subsidiary Noumed signed a 7.5-year OTC supply pact worth AUD 202 million, as FY26 results reflected Noumed’s part-year consolidation.
Lupin’s subsidiary Nanomi signed deals for a 43.38% stake in MPPI and later saw its holding rise to 56.28% after MPPI’s buyback, with shares reacting on the BSE.
SEBI barred 222 entities for 4-7 years in alleged pump-and-dump schemes across five stocks, ordering ₹143.79 crore disgorgement and imposing ₹47.7 crore penalties.
Gala Global Products told BSE its board will meet on May 30, 2026 to approve FY26 audited standalone results, after filing revised Q3 FY26 numbers.